Perspective · 10 Sep 2026
Conference abstractPublished 29 Sep 2014
Induction of protective cellular and humoral responses against fasciolosis in rabbits using immunoaffinity fraction of Fasciola gigantica excretory secretory products
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fasciolosis due to Fasciola gigantica or F. hepatica causes significant production losses in animals, as well as being a zoonotic disease of global importance. In an attempt to develop vaccine against fasciolosis in rabbits, an immunoaffinity fraction of F. gigantica excretory secretory products was isolated. The fraction possesses 87.67% of the initial antigenic activities in ES products with 2051.5 fold increase in specific activity compared to crude extract. It consists of two bands of molecular weight 27 KDa and 23.5 KDa as revealed by SDS-PAGE. Vaccination of rabbits twice with the fraction resulted in 85.7% reduction in worm burden. It is also resulted in high antibody IgG levels as proved by ELISA, were the highest IgG response was observed at two weeks post first immunization compared to non-vaccinated infected control rabbits. The level of IgG increased at four weeks post infection and remained stable to the end of the experiment. A significant expression of IL-4 and INF-gamma was observed in vaccinated rabbits starting one week until thirteen weeks post infection. The level of IL-4 was significantly higher than the level of INF-gamma throughout the experiment. Collectively, the current results suggest promising immunoprophylactic potentials of the immunoaffinity fraction of ES products of F. gigantica against fasciolosis in rabbits through induction of both cellular and humoral responses.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Eman H Abdel-Rahman”
- BylineArticles whose byline prints “Sanaa K A Abou-El-Douba”
- BylineArticles whose byline prints “Soad E Hassan”
- BylineArticles whose byline prints “Nagwa I Toaleb”
- BylineArticles whose byline prints “A G Hegazi”
